Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$16.0 - $45.99 $8.72 Million - $25.1 Million
-544,723 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$33.17 - $46.98 $6.84 Million - $9.69 Million
206,266 Added 60.94%
544,723 $24.4 Million
Q4 2021

Feb 15, 2022

BUY
$39.06 - $67.58 $4.19 Million - $7.24 Million
107,161 Added 46.33%
338,457 $14.5 Million
Q3 2021

Nov 16, 2021

BUY
$60.13 - $77.6 $966,770 - $1.25 Million
16,078 Added 7.47%
231,296 $15.4 Million
Q2 2021

Aug 17, 2021

BUY
$50.07 - $76.78 $8.81 Million - $13.5 Million
175,879 Added 447.09%
215,218 $15.8 Million
Q1 2021

May 18, 2021

BUY
$58.92 - $97.33 $1.8 Million - $2.97 Million
30,520 Added 346.07%
39,339 $2.69 Million
Q3 2020

Nov 17, 2020

SELL
$38.47 - $52.03 $80,056 - $108,274
-2,081 Reduced 19.09%
8,819 $454,000
Q2 2020

Aug 13, 2020

SELL
$27.28 - $43.01 $111,166 - $175,265
-4,075 Reduced 27.21%
10,900 $411,000
Q1 2020

May 18, 2020

SELL
$23.08 - $35.53 $398,129 - $612,892
-17,250 Reduced 53.53%
14,975 $446,000
Q4 2019

Feb 14, 2020

SELL
$15.74 - $35.04 $742,141 - $1.65 Million
-47,150 Reduced 59.4%
32,225 $1.11 Million
Q3 2019

Nov 14, 2019

BUY
$18.09 - $27.92 $1.44 Million - $2.22 Million
79,375 New
79,375 $1.44 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $706M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Grandeur Peak Global Advisors, LLC Portfolio

Follow Grandeur Peak Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.